Dr. Peter Marks, the top Food and Drug Administration official whose forced resignation earlier this year set off a panic among biotech investors, is now an executive at Eli Lilly the company said on Tuesday. Marks stepped down as the chief of the FDA’s Center for Biologics Evaluation and Research in March. Lilly says he started work this month.
Continue Reading
View Comments
Former Top FDA Official, Forced Out by Kennedy, Lands at Eli Lilly
Published 1 month ago
Oct 7, 2025 at 9:04 PM
Negative
Auto